Skip to main content
Fig. 8 | Stem Cell Research & Therapy

Fig. 8

From: Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial

Fig. 8

Representative images from chest CT at the level of the lower lobes in patients from the treatment and control groups. Red arrows point to ground-glass opacification, blue arrows to peripheral consolidations, and the yellow arrow to crazy-paving, all of which are typical features of COVID-19. It is possible to note the higher degree of clearance in patients from the treatment group (first line) compared to the control group (last line). UC-MSC, umbilical cord mesenchymal stromal cell

Back to article page